Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.730
-0.040 (-2.26%)
Sep 3, 2025, 4:00 PM - Market closed
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $275.24 million as of September 4, 2025. Its market cap has decreased by -58.62% in one year.
Market Cap
275.24M
Enterprise Value
219.71M
1-Year Change
-58.62%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $275.24M, an increase of 120.49%. That is a compound annual growth rate of 13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 275.24M | -49.23% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |